1. Home
  2. VRME vs AIDX Comparison

VRME vs AIDX Comparison

Compare VRME & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.70

Market Cap

8.2M

Sector

Technology

ML Signal

HOLD

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.43

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VRME
AIDX
Founded
1999
N/A
Country
United States
United States
Employees
30
14
Industry
EDP Services
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
6.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VRME
AIDX
Price
$0.70
$0.43
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
36.8K
124.8K
Earning Date
05-13-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$36.85
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.40
52 Week High
$1.51
$14.09

Technical Indicators

Market Signals
Indicator
VRME
AIDX
Relative Strength Index (RSI) 57.09 29.57
Support Level $0.66 N/A
Resistance Level $0.75 $0.57
Average True Range (ATR) 0.04 0.04
MACD 0.01 0.00
Stochastic Oscillator 72.91 15.90

Price Performance

Historical Comparison
VRME
AIDX

About VRME VerifyMe Inc.

VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: